Ontology highlight
ABSTRACT: Background
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Given its often-paroxysmal nature, screening at a single time point, using a 12-lead electrocardiogram (ECG) or a Holter monitor, has limited benefit. The AliveCor KardiaMobile device is a validated ECG recorder that can be used for patient-directed arrhythmia diagnosis and symptom-rhythm correlation. The aim of this study was to evaluate whether using the KardiaMobile device could reduce the time-to-diagnosis, for AF as well as other arrhythmias. We hypothesized that providing patients with a KardiaMobile device during their waiting period for specialist care could reduce the length of time that passes before ECG detection of arrhythmia.Methods
Patients were randomized 1:1 to receive either standard
SUBMITTER: Coxon MW
PROVIDER: S-EPMC11681358 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature